BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1337 related articles for article (PubMed ID: 1908481)

  • 1. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB; Lanzendorf SE; Wolf DP; Chandrasekher YA; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells.
    Chandrasekher YA; Brenner RM; Molskness TA; Yu Q; Stouffer RL
    J Clin Endocrinol Metab; 1991 Sep; 73(3):584-9. PubMed ID: 1908482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge.
    Chandrasekher YA; Hutchison JS; Zelinski-Wooten MB; Hess DL; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1994 Jul; 79(1):298-306. PubMed ID: 8027245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
    Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
    Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM; Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function.
    Zelinski-Wooten MB; Hess DL; Baughman WL; Molskness TA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1993 Apr; 76(4):988-95. PubMed ID: 8473415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
    Fauser BC; de Jong D; Olivennes F; Wramsby H; Tay C; Itskovitz-Eldor J; van Hooren HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):709-15. PubMed ID: 11836309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
    Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
    Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the timing of controlled internal drug-releasing device insertion on the gonadotropin-releasing hormone-induced luteinizing hormone surge and ovulatory response.
    Perry GA; Perry BL
    J Anim Sci; 2009 Dec; 87(12):3983-90. PubMed ID: 19684266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
    Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
    J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS; Zeleznik AJ
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
    Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the role of LH in the maturation of the pre-ovulatory follicle in a sheep using a GnRH-antagonist.
    Campbell BK; Dobson H; Baird DT; Scaramuzzi RJ
    Anim Reprod Sci; 1997 Aug; 48(2-4):219-34. PubMed ID: 9452875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys.
    Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
    Hum Reprod; 1995 Jul; 10(7):1658-66. PubMed ID: 8582957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.